We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWLO icon
2501
CALL
Twilio
TWLO
$36.6B
$4.34M ﹤0.01%
183,900
-54,200
-23% -$1.52M
CTRA
2502
CALL
DELISTED
Coterra Energy
CTRA
$4.34M ﹤0.01%
151,600
-17,600
-10% -$483K
PHM icon
2503
PUT
Pultegroup
PHM
$24.8B
$4.34M ﹤0.01%
130,400
+49,600
+61% +$1.54M
EPI icon
2504
PUT
WisdomTree India Earnings Fund ETF
EPI
$2.03B
$4.33M ﹤0.01%
155,700
-16,700
-10% -$445K
ROP icon
2505
PUT
Roper Technologies
ROP
$39.5B
$4.33M ﹤0.01%
16,700
-6,800
-29% -$1.75M
NKTR icon
2506
PUT
Nektar Therapeutics
NKTR
$2.49B
$4.32M ﹤0.01%
4,827
+4,194
+663% +$2.48M
GBX icon
2507
PUT
The Greenbrier Companies
GBX
$1.41B
$4.32M ﹤0.01%
81,100
+51,500
+174% +$2.58M
LH icon
2508
PUT
Labcorp
LH
$25.8B
$4.32M ﹤0.01%
31,544
+26,306
+502% +$3.48M
STRA icon
2509
Strategic Education
STRA
$1.83B
$4.32M ﹤0.01%
48,230
+10,445
+28% +$965K
CDK
2510
PUT
DELISTED
CDK Global, Inc.
CDK
$4.32M ﹤0.01%
60,600
+48,700
+409% +$3.27M
SPB icon
2511
CALL
Spectrum Brands
SPB
$2.07B
$4.32M ﹤0.01%
38,400
-223,100
-85% -$24.4M
CPN
2512
CALL
DELISTED
Calpine Corporation
CPN
$4.32M ﹤0.01%
285,300
+73,700
+35% +$1.1M
FE icon
2513
PUT
FirstEnergy
FE
$27.4B
$4.3M ﹤0.01%
140,600
+69,900
+99% +$2.27M
WW
2514
CALL
DELISTED
WW International
WW
$4.3M ﹤0.01%
97,200
-4,900
-5% -$223K
SCG
2515
PUT
DELISTED
Scana
SCG
$4.3M ﹤0.01%
108,200
+75,800
+234% +$3.39M
QSR icon
2516
PUT
Restaurant Brands International
QSR
$27.1B
$4.3M ﹤0.01%
69,900
+27,700
+66% +$1.78M
HIMX
2517
CALL
Himax Technologies
HIMX
$2.66B
$4.29M ﹤0.01%
412,200
+166,600
+68% +$1.81M
EFX icon
2518
Equifax
EFX
$21.2B
$4.29M ﹤0.01%
36,393
-117,715
-76% -$13.2M
FNGN
2519
DELISTED
Financial Engines, Inc.
FNGN
$4.29M ﹤0.01%
141,611
-18,193
-11% -$571K
FMC icon
2520
CALL
FMC
FMC
$1.27B
$4.29M ﹤0.01%
52,231
+1,499
+3% +$120K
TSEM icon
2521
PUT
Tower Semiconductor
TSEM
$30B
$4.29M ﹤0.01%
125,800
+36,900
+42% +$1.22M
ALSN icon
2522
CALL
Allison Transmission
ALSN
$10.4B
$4.28M ﹤0.01%
99,400
+21,300
+27% +$868K
M icon
2523
Macy's
M
$6.16B
$4.28M ﹤0.01%
169,937
-211,073
-55% -$4.63M
CCT
2524
DELISTED
Corporate Capital Trust, Inc.
CCT
$4.28M ﹤0.01%
+267,725
New +$4.69M
MC icon
2525
Moelis & Co
MC
$5.07B
$4.28M ﹤0.01%
88,181
-80,344
-48% -$3.63M

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.